Current Trends in Pharmacy and Pharmaceutical Chemistry open access, peer-reviewed quarterly journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research, aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. With the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would more...
Self- Archiving Policy
Current Trends in Pharmacy and Pharmaceutical Chemistry is committed to upholding the integrity of the scientific record, Publication Ethics and Publication Malpractice Statement is based on the Code of Conduct and Best Publishing Practice and COPE Guidelines for Journal.
Publication Decisions: The editors are responsible for deciding on accepting, rejecting or modification requests to the manuscript. In some instances, the editors may require multiple rounds of reviews and modifications. The editors communicated review results in a timely decision and were always willing to publish corrections, clarifications, retractions and maintain the integrity of the academic record. The editor reserves the right to edit, clarify or shorten the manuscript as deemed necessary.
Fair Review Process:The editor's decisions to accept or reject a paper for publication should be based only on the papers importance, originality and clarity, and the study relevance to the journal. The editor must ensure that each manuscript submitted to the journal is reviewed for its intellectual content without regards to the authors’ race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. The decisions will be based on the paper's importance, originality, clarity, and relevance to the journal's scope.
Confidentiality:The editor and editorial staff always ensure that information regarding manuscripts submitted by the authors is kept confidential.
Disclosure and Conflicts of Interest:The editor and members of the editorial board of the journal shall not use unpublished material disclosed in a submitted manuscript for his/her own research without the author’s explicit written consent.
Relations with Authors:Editors should take all reasonable steps to ensure the quality of the material they publish, recognising the journal and sections within journals with different aims and standards. The guideline should be regularly updated and should refer or link. Editors should not reverse decisions to accept submission unless serious problems are identified with the submission.
Publication guidelines: Authors must follow the submission guidelines of the journal.
Confidentiality: Reviewers must keep all manuscripts received confidential. Any manuscripts received for review are confidential documents and must be treated as such, they must not be shown to or discussed with others and articles should be treated confidentially.
Objectives and Standards: Reviews should be conducted objectively. Personal criticism of the author is inappropriate.
Conflicts of Interest: Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative and other relationships or connections with any of the authors, associated institutions and companies with the paper(s).
Promptness: in the event that a reviewer feels it is not possible for his/her to complete review of manuscript within the stipulated time he/she should notify the editor in a timely manner and withdraw from the review process.
Acknowledgement of sources: Reviewers must ensure that authors have cited all relevant published work referred to the paper in the endnotes and bibliography. Reviewers will bring to the editors’ attention any substantial similarity or overlap between the manuscript and any other published or unpublished content. Authors should not use information obtained in the course of providing confidential services, such as refereeing manuscripts or grant applications, unless they have obtained the explicit written permission of the author(s) of the work involved in review.
Review evaluation: Reviewers evaluate manuscripts based on content without regard to the authors’ race, age, gender, ethnic origin, sexual orientation, disability, religious belief, citizenship, political orientation or social class.
Current Trends in Pharmacy and Pharmaceutical Chemistry follows the high standards of peer review policy as set out in the COPE Ethical Guidelines for publication ethics practice for Peer Reviewers.
All research manuscripts and other types are subjected to thorough peer-review, usually by at least two external peer-reviewers. After initial scrutiny by the journal editors for suitability in the journal, the editor will invite appropriate independent reviewers with sufficient and specific areas of expertise. The editor will invite appropriate independent reviewers with sufficient and specific areas of expertise. The editor decision is made based on these reviewer reports, which are made available to the authors upon decision. Where the editor of the journal is an author is the submission, adequate steps are taken to ensure blinding the editor from the submission during peer-review. Further information about the journal's specific model of peer-review is found on the journal’s information pages.
Duplicate Submission: If duplicate submission was found or noticed from other sources, the editorial board should check the status. If the duplicate submission was confirmed as an internal thing, then the following actions must be imposed. Review process will be terminated, the reason should be sent to reviewers, editorial board, authors and corresponding authors and all authors’ names will be marked as black listed, and these authors cannot submit any manuscript to these journals for another three years.
Duplicate Publication: if duplicate publication is found or noticed from other sources, the editorial board should check the status. If the duplicate publication is confirmed as intentional, then the following actions will be carried out. This should be reported to editors, authors etc.
Plagiarism: “To steal and pass off the ideas or words of another as one’s own, use another’s production without crediting the source” or “present as new and original an idea or product derived from an existing source”. We consider “self-plagiarism” as a form of plagiarism. Self-plagiarism would be when an author borrows from his or her own previously published work without the proper citation within the newly submitted manuscript. We use iThenticate software for check plagiarism. If plagiarism is found or noticed from other sources, the editorial board should check the status. If the plagiarism is confirmed as an international thing, then the following actions will be carried out. This should be reported to the editorial board, authors and corresponding author and all authors' names will be marked as black list.
We follow the latest Core Practice Guidelines for Editors, Reviewers, Authors and Publishers as outlined by the COPE.